Clinical utility of nuchal translucency screening

References

• Benacerraf BR, Frigoletto FD Jr, Laboda LA. Sonographic diagnosis of Down syndrome in the second trimester. Am J Obstet Gynecol. 1985;153(1):49–52.
   Web of Science ®Google Scholar
• Szabó J, Gellén J. Nuchal fluid accumulation in trisomy-21 detected by vaginosonography in first trimester. Lancet. 1990;336(8723):1133.
   Web of Science ®Google Scholar
• Nicolaides KH, Azar G, Byrne D, Mansur C, Marks K. Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy. BMJ. 1992;304(6831):867–869.
   PubMed Web of Science ®Google Scholar
• Nicolaides KH, Brizot ML, Snijders RJ. Fetal nuchal translucency: ultrasound screening for fetal trisomy in the first trimester of pregnancy. Br J Obstet Gynaecol. 1994;101(9):782–786.
   PubMedGoogle Scholar
• Pajkrt E, Bilardo CM, van Lith, Mol BW, Bleker OP. Nuchal translucency measurement in normal fetuses. Obstet Gynecol. 1995;86(6):994–997.
   Web of Science ®Google Scholar
• Nicolaides KH, Heath V, Cicero S. Increased fetal nuchal translucency at 11–14 weeks. Prenat Diagn. 2002;22(4):308–315.
   PubMed Web of Science ®Google Scholar
• Maymon R, Tercanli S, Dreazen E, Sartorius G, Holzgreve W, Herman A. Comparison of pregnancy outcome of euploid fetuses with increased nuchal translucency (NT) expressed in NT MoM or delta-NT. Ultrasound Obstet Gynecol. 2004;23(5):477–481.
   Web of Science ®Google Scholar
• Hafner E, Schuchter K, Philipp K. Screening for chromosomal abnormalities in an unselected population by fetal nuchal translucency. Ultrasound Obstet Gynecol. 1995;6(5):330–333.
   Web of Science ®Google Scholar
• Wald NJ, Kennard A, Hackshaw A, McGuire A. Antenatal screening for Down’s syndrome. Health Technol Assess. 1998;2(1):i–iv, 111–112.
   Google Scholar
• Blakemore KJ. Nuchal translucency. Ultrasound Obstet Gynecol. 1998;11(6):388–390.
   Web of Science ®Google Scholar
• Haak MC, van Vugt JMG. Pathophysiology of increased nuchal translucency: a review of the literature. Hum Reprod Update. 2003;9(2):175–184.
   Web of Science ®Google Scholar
• Bekker MN, Arkesteijn JB, van den Akker HM, et al. Increased NCAM expression and vascular development in trisomy 16 mouse embryos: relationship with nuchal translucency. Pediatr Res. 2005;58(6):1222–1227.
   Web of Science ®Google Scholar
• Nafziger E, Vilensky JA. The anatomy of nuchal translucency at 10–14 weeks gestation in fetuses with Trisomy 21: An incredible medical mystery. Clin Anat. 2014;27:353–359.
   Web of Science ®Google Scholar
• Nicolaides KH. Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities. Am J Obstet Gynecol. 2004;191(1):45–67.
   PubMed Web of Science ®Google Scholar
• Snijders RJ, Noble P, Sebire N, Souka A, Nicolaides KH. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10–14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group. Lancet. 1998;352(9125):343–346.
   PubMed Web of Science ®Google Scholar
• Äyräs, O, Tikkanen M, Eronen M, Paavonen J, Stefanovic V. Increased nuchal translucency and pregnancy outcome: a retrospective study of 1063 consecutive singleton pregnancies in a single referral institution. Prenat Diagn. 2013;33:856–862.
   PubMed Web of Science ®Google Scholar
• Bilardo CM, Müller MA, Pajkrt E, Clur SA, van Zalen MM, Bijlsma EK. Increased nuchal translucency thickness and normal karyotype: time for parental reassurance. Ultrasound Obstet Gynecol. 2007;30(1):11–18.
   PubMed Web of Science ®Google Scholar
• Savage MS, Mourad MJ, Wapner RJ. Evolving applications of microarray analysis in prenatal diagnosis. Curr Opin Obstet Gynecol. 2011;23(2):103–108.
   Web of Science ®Google Scholar
• Reiff M, Bernhardt BA, Mulchandani S, et al. “What does it mean?”: Uncertainties in understanding results of chromosomal microarray testing. Genet Med. 2012;14(2):250–258.
   Web of Science ®Google Scholar
• Chew C, Halliday JL, Riley MM, Penny DJ. Population-based study of antenatal detection of congenital heart disease by ultrasound examination. Ultrasound Obstet Gynecol. 2007;29(6):619–624.
   PubMed Web of Science ®Google Scholar
• Hyett J, Perdu M, Sharland G, Snijders R, Nicolaides KH. Using fetal nuchal translucency to screen for major congenital cardiac defects at 10–14 weeks of gestation: population based cohort study. BMJ. 1999;318(7176):81–85.
   PubMed Web of Science ®Google Scholar
• Wald NJ, Kennard A. Routine ultrasound scanning for congenital abnormalities. Ann N Y Acad Sci. 1998;847:173–180.
   PubMed Web of Science ®Google Scholar
• Wald NJ, Morris JK, Walker K, Simpson JM. Prenatal screening for serious congenital heart defects using nuchal translucency: a meta-analysis. Prenat Diagn. 2008;28(12):1094–1104.
   Web of Science ®Google Scholar
• Wald NJ, Rodeck C, Hackshaw AK, Walters J, Chitty L, Mackinson AM. First and second trimester antenatal screening for Down’s syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS). J Med Screen. 2003;10:56–104.
   PubMed Web of Science ®Google Scholar
• Khoshnood B, De Vigan C, Vodovar V, et al. Trends in prenatal diagnosis, pregnancy termination, and perinatal mortality of newborns with congenital heart disease in France, 1983–2000: a population-based evaluation. Pediatrics. 2005;115(1):95–101.
   PubMed Web of Science ®Google Scholar
• Arigita M, Borrell A, Mula R, Sanchez A, Milà M, Gratacos E. Use of fetal nuchal translucency in the first trimester to predict single-gene disorders. Prenat Diagn. 2011;31(12):1164–1168.
   Web of Science ®Google Scholar
• Pergament E, Alamillo C, Sak K, Fiddler M. Genetic assessment following increased nuchal translucency and normal karyotype. Prenat Diagn. 2011;31(3):307–310.
   Web of Science ®Google Scholar
• Mangione R, Guyon F, Taine L, et al. Pregnancy outcome and prognosis in fetuses with increased first-trimester nuchal translucency. Fetal Diagn Ther. 2001;16(6):360–363.
   Web of Science ®Google Scholar
• Souka AP, Krampl E, Bakalis S, Heath V, Nicolaides KH. Outcome of pregnancy in chromosomally normal fetuses with increased nuchal translucency in the first trimester. Ultrasound Obstet Gynecol. 2001;18(1):9–17.
   PubMed Web of Science ®Google Scholar
• Michailidis GD, Economides DL. Nuchal translucency measurement and pregnancy outcome in karyotypically normal fetuses. Ultrasound Obstet Gynecol. 2001;17(2):102–105.
   PubMed Web of Science ®Google Scholar
• Senat MV, De KB, Audibert F, Montcharmont G, Frydman R, Ville Y. Pregnancy outcome in fetuses with increased nuchal translucency and normal karyotype. Prenat Diagn. 2002;22(5):345–349.
   PubMed Web of Science ®Google Scholar
• Bilardo CM, Timmerman E, Pajkrt E, van Maarle M. Increased nuchal translucency in euploid fetuses – what should we be telling the parents? Prenat Diagn. 2010;30:93–102.
   PubMed Web of Science ®Google Scholar
• Taylor MJ, Denbow ML, Tanawattanacharoen S, Gannon C, Cox PM, Fisk NM. Doppler detection of arterio-arterial anastomoses in monochorionic twins: feasibility and clinical application. Hum Reprod. 2000:15(7):1632–1636.
   Web of Science ®Google Scholar
• Zoppi MA. Nuchal translucency screening in monochorionic twin pregnancies. Ultrasound Obstet Gynecol. 2009;34(5):491–493.
   Web of Science ®Google Scholar
• Sebire NJ, Souka A, Skentou H, Geerts L, Nicolaides KH. Early prediction of severe twin-to-twin transfusion syndrome. Hum Reprod. 2000;15(9):2008–2010.
   PubMed Web of Science ®Google Scholar
• Kagan K, Gazzoni A, Sepulveda-Gonzalez, Sotiriadis A, Nicolaides, KH. Discordance in nuchal translucency thickness in the prediction of severe twin-to-twin transfusion syndrome. Ultrasound Obstet Gynecol. 2007;29(5):527–532.
   PubMed Web of Science ®Google Scholar
• Fratelli N, Prefumo F, Fichera A, Valcamonico A, Marella D, Frusca T. Nuchal translucency thickness and crown rump length discordance for the prediction of outcome in monochorionic diamniotic pregnancies. Early Hum Dev. 2011;87(1):27–30.
   PubMed Web of Science ®Google Scholar
• Antsaklis A, Pergialiotis V, Theodora M, Papazefkos V, Antsaklis P. Early prediction of Twin-to-Twin Transfusion Syndrome with the use of First Trimester Ultrasound Markers: Is it Possible? Donald School J Ultrasound Obstet Gynecol. 2013;781:66–72.
   Google Scholar
• Cuckle H, Maymon R. Down syndrome risk calculation for a twin fetus taking account of the nuchal translucency in the co-twin. Prenat Diagn. 2010;30:827–833.
   PubMed Web of Science ®Google Scholar
• Matias A, Montenegro N, Loureiro T, et al. Screening for twin–twin transfusion syndrome at 11–14 weeks of pregnancy: The key role of ductus venosus blood flow assessment. Ultrasound Obstet Gynecol. 2010;35(2):142–148.
   PubMed Web of Science ®Google Scholar
• Sebire NJ, Snijders RJ, Hughes K, Sepulveda W, Nicolaides KH. Screening for trisomy 21 in twin pregnancies by maternal age and fetal nuchal translucency thickness at 10–14 weeks of gestation. Br J Obstet Gynaecol. 1996;103(10):999–1003.
   Google Scholar
• Audibert F, Gagnon A, Genetics Committee of the Society of Obstetricians and Gynaecologists of Canada; Prenatal Diagnosis Committee of the Canadian College of Medical Geneticists. Prenatal screening for and diagnosis of aneuploidy in twin pregnancies. J Obstet Gynaecol Can. 2011;33(7):754–767.
   Google Scholar
• Nobili E, Paramasivam G, Kumar S. Outcome following selective fetal reduction in monochorionic and dichorionic twin pregnancies discordant for structural, chromosomal and genetic disorders. Aust N Z J Obstet Gynaecol. 2013;53(2):114–118.
   PubMed Web of Science ®Google Scholar
• Brady AF, Pandya PP, Yuksel B, Greenough A, Patton MA, Nicolaides KH. Outcome of chromosomally normal livebirths with increased fetal nuchal translucency at 10–14 weeks’ gestation. J Med Genet. 1998;35(3):222–224.
   Web of Science ®Google Scholar
• Hiippala A, Eronen M, Taipale P, Salonen R, Hiilesmaa V. Fetal nuchal translucency and normal chromosomes: a long-term follow-up study. Ultrasound Obstet Gynecol. 2001;18(1):18–22.
   Web of Science ®Google Scholar
• Senat MV, Bussieres L, Couderc S, et al. Long-term outcome of children born after a first-trimester measurement of nuchal translucency at the 99th percentile or greater with normal karyotype: a prospective study. Am J Obstet Gynecol. 2007;196(1):53. e1–e6.
   Web of Science ®Google Scholar
• Schou KV, Kirchhoff M, Nygaard U, Jorgensen C, Sundberg K. Increased nuchal translucency with normal karyotype: a follow-up study of 100 cases supplemented with CGH and MLPA analyses. Ultrasound Obstet Gynecol. 2009;34(6):618–622.
   Web of Science ®Google Scholar
• Mula R, Gonce A, Bennasar M, et al. Increased nuchal translucency and normal karyotype: perinatal and pediatric outcomes at 2 years of age. Ultrasound Obstet Gynecol. 2012;39(1):34–41.
   Web of Science ®Google Scholar
• Miltoft CB, Ekelund CK, Hansen BM, et al. Increased nuchal translucency, normal karyotype and infant development. Ultrasound Obstet Gynecol. 2012;39(1):28–33.
   Web of Science ®Google Scholar
• Raffle AE. Information about screening – is it to achieve high uptake or to ensure informed choice? Health Expect. 2001;4(2):92–98.
   PubMedGoogle Scholar
• van den Berg M, Timmermans DR, ten Kate LP, van Vugt JM, van der Wal G. Informed decision making in the context of prenatal screening. Patient Educ Couns. 2006;63(1–2):110–117.
   PubMed Web of Science ®Google Scholar
• Dahl K, Hvidman L, Jørgensen FS, Kesmodel US. Knowledge of prenatal screening and psychological management of test decisions. Ultrasound Obstet Gynecol. 2011;38(2):152–157.
   Web of Science ®Google Scholar